Clinical Research
Platelets and Stent Thrombosis
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis: Results of the CREST Study

https://doi.org/10.1016/j.jacc.2005.07.056Get rights and content
Under an Elsevier user license
open archive

Objectives

We investigated whether patients who suffered subacute stent thrombosis (SAT) have higher post-treatment reactivity than those who do not encounter stent thrombosis.

Background

High post-treatment platelet reactivity has been reported after coronary stenting after clopidogrel therapy and may be an important factor in the occurrence of SAT.

Methods

We identified patients with SAT treated at two tertiary care centers over a 1.5-year period. Light transmittance aggregation induced by adenosine diphosphate (ADP) and arachidonic acid, total and activated glycoprotein (GP) IIb/IIIa after stimulation with ADP, and vasodilator-stimulated phosphoprotein phosphorylation levels to measure P2Y12receptor inhibition were determined (n = 20) and compared with an age-matched group of patients without SAT (n = 100). High post-treatment platelet reactivity was defined as >75th percentile ADP-induced aggregation in the group without SAT.

Results

The SAT patients had higher mean platelet reactivity than those without SAT by all measurements (p < 0.05): 49 ± 4% versus 33 ± 2% for 5 μmol/l ADP-induced aggregation and 65 ± 3% versus 51 ± 2% for 20 μmol/l ADP-induced aggregation (p < 0.001), 69 ± 5% versus 46 ± 9% for P2Y12reactivity ratio (p = 0.03), and 138 ± 19 mean fluorescence intensity (MFI) versus 42 ± 4 MFI for stimulated GP IIb/IIIa expression (p < 0.001). Of patients with SAT, 60% had high platelet reactivity.

Conclusions

High post-treatment platelet reactivity and incomplete P2Y12receptor inhibition are risk factors for SAT. Measures to uniformly determine platelet reactivity after coronary stenting and treatment strategies to improve P2Y12receptor inhibition in patients with high post-treatment platelet reactivity should be further investigated.

Abbreviations and Acronyms

ADP
adenosine diphosphate
GP
glycoprotein
MFI
mean fluorescence intensity
PGE1
prostaglandin E1
SAT
stent thrombosis
VASP
vasodilator-stimulated phosphoprotein

Cited by (0)

This study was supported by a grant from Astra Zeneca LP, Wilmington, Delaware.